Abstract
ObjectiveTo assess the utility of laparoscopy for interval cytoreductive surgery (CRS) in patients with advanced ovarian cancer after Neo-Adjuvant Chemotherapy (NACT). MethodsA retrospective cohort study of interval CRS by laparoscopy in patients with advanced epithelial ovarian cancer treated at a single tertiary gynaecological cancer centre between October 2017 and September 2020. Results86 patients had interval CRS by the laparoscopic route during the study period. The optimal cytoreduction rate (R < 1 cm) was 92%, and complete cytoreduction rate with no residual disease (R = 0) was 35%. The intra-operative complication rate was 8% and the estimated blood loss (EBL) was 90 ml. The post-operative complication rate was 15%, mostly grade I-II, and the median length of hospital stay was 3 days. ConclusionFor most patients with advanced ovarian cancer after NACT, laparoscopic interval CRS is feasible and effective in achieving optimal cytoreduction while providing a favourable peri-operative outcome. In some cases, however, recourse to laparotomy will optimise complete macroscopic resection.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
